Care During Chemotherapy and Beyond
Chemocare.com uses generic names in all descriptions of drugs. Anagrelide is the generic name for Agrylin®. In some cases, health care professionals may use the trade
name Agrylin® when referring to the generic drug name anagrelide.
Anagrelide is considered a "phospholipase A2 inhibitor." (For more detail, see "How this drug works" below).
What anagrelide is used for:
- To treat primary thrombocythemia, a blood disorder in which there are too many platelets in the blood.
If a drug has been approved for one use, physicians may elect to use this same drug for other problems if they believe it may be helpful.
How anagrelide is given:
- Anagrelide comes in capsule form, to be taken by mouth.
- The amount of this medication that you receive, your schedule and how long you take it depends on many factors. Your doctor will determine your dosage
Important things to remember about the side effects of anagrelide:
- Most people do not experience all of the side effects listed.
- Side effects are often predictable in terms of their onset and duration.
- Side effects are almost always reversible and will go away after treatment is complete.
- There are many options to help minimize or prevent side effects.
- There is no relationship between the presence or severity of side effects and the effectiveness of the medication.
The following side effect is common (occurring in greater than 30%) for patients taking anagrelide:
The following side effects are less common (occurring in 10-29%) for patients taking anagrelide:
Not all side effects are listed above, some that are rare (occurring in less than 10% of patients) are not listed here. However, you should always
inform your health care provider if you experience any unusual symptoms.
When to contact your doctor or health care provider:
Contact your health care provider immediately, day or night, if you should experience any of the following symptoms:
- Fever of 100.4° F (38° C) or higher, chills (possible signs of infection)
Contact your health care provider immediately and go to the ER
if you experience any signs or symptoms of heart problems such as: anxiety, cold sweating, increased heart rate, severe pain in the chest and/or the
jaw, neck, back, or arms, and shortness of breath.
The following symptoms require medical attention, but are not an emergency. Contact your health care provider within 24 hours of
noticing any of the following:
- Nausea (interferes with ability to eat and unrelieved with prescribed medication).
- Diarrhea (4 to 6 episodes in a 24-hour period).
- Unusual bleeding or bruising.
- Black or tarry stools, or blood in your stools or urine.
- Bleeding from the gums or vaginal bleeding that is not normal.
- Coughing up blood-tinged sputum.
- Swelling of the feet or ankles.
- Sudden weight gain.
- Signs of breathing problems such as cough, shortness of breath, or trouble breathing
- Signs of pancreatitis like very bad stomach pain, very bad back pain or very bad upset stomach or throwing up.
- Change in thinking clearly or problems with memory.
- Very bad headache.
- A burning, numbness, or tingling feeling that is not normal.
- Change in strength on 1 side, trouble speaking, change in balance or blurred eyesight.
- Extreme fatigue (unable to carry on self-care activities).
Always inform your health care provider if you experience any unusual symptoms.
- Before starting anagrelide treatment, make sure you tell your doctor about any other medications you are taking (including prescription,
over-the-counter, vitamins, herbal remedies).
- Tell your health care provider if you have ever had any heart problems including a long QT on an ECG.
- Inform your health care professional if you are pregnant or may be pregnant prior to starting this treatment. Pregnancy category C (use in pregnancy
only if benefit to mother outweighs risk to fetus).
- For both men and women: Do not conceive a child (get pregnant) while taking anagrelide. Barrier methods of contraception, such as condoms, are
recommended. Discuss with your doctor when you may safely become pregnant or conceive a child after therapy.
- Do not breast feed while taking this medication.
- You may feel drowsy and/or dizzy when you first start taking anagrelide. This should lessen as your body adjusts to the drug. Do not drive a car or
operate machinery if you are feeling drowsy, dizzy or less alert than usual.
- You may bleed more easily. Be careful and avoid injury. Use a soft toothbrush and an electric razor.
- To reduce nausea, take anti-nausea medications as prescribed by your doctor, and eat small, frequent meals.
- Drink at least two to three quarts of fluid every 24 hours, unless you are instructed otherwise.
- In general, drinking alcoholic beverages should be minimized or avoided. You should discuss this with your doctor.
- Get plenty of rest.
- Maintain good nutrition.
Monitoring and testing:
You will be monitored carefully and regularly by your doctor while you are taking anagrelide. Before beginning this therapy and during treatment, your
cardiovascular (heart) health will be assessed. Blood tests and other monitoring will be done periodically throughout your treatment program to spot any
side effects early on and to assess your response to the medicine.
How this drug works:
Thrombocythemia is a blood disorder in which there are too many platelets found in the blood. The megakaryocyte is the cell type from which platelets are
produced. It is in the mature stage of the megakaryocyte's development that platelets are formed. If this maturation process is stopped platelets are
unable to be produced.
Anagrelide interferes with the megakaryocyte maturation. It does this by blocking an enzyme (phospholipase A2) which is needed for completing the
maturation process of megakaryocytes.
We strongly encourage you to talk with your health care professional about your specific medical condition and treatments. The information contained in
this website is meant to be helpful and educational, but is not a substitute for medical advice.
5-Azacitidine.Lexicomp Online® [updated 2015 July 27th; cited 2015 September 8th].Lexi-Drugs®. Hudson, Ohio: Lexi-Comp, Inc.;
September 8th, 2015.
Chemocare.com is designed to provide the latest information about chemotherapy to patients and their families, caregivers and friends. For information about the 4th Angel Mentoring Program visit www.4thangel.org